Stockreport

Starpharma Announces a Collaboration and License Agreement with Genentech

STARPHARMA HLDGS S/ADR  (SPHRY) 
NASDAQ:AMEX Investor Relations: starpharma.com/investor_centre
PDF MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology company, today announced the sign [Read more]